US3596641098
US3596641098
Fulgent Genetics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 322.671.000 | 283.470.000 | 13.8% |
| Cost of Revenue | 191.796.000 | 176.255.000 | 8.8% |
| Gross Profit | 130.875.000 | 107.215.000 | 22.1% |
| 221.971.000 | 181.133.000 | 22.5% | |
| Operating Income | -91.096.000 | -73.918.000 | 23.2% |
| Pretax Income | -70.025.000 | -51.956.000 | 34.8% |
| Net Income Common Stockholders | -60.513.000 | -42.708.000 | 41.7% |
| -- | -- | -- | |
| -- | -- | -- |